News

“Delete-To-Recruit” – Scientists Discover Simpler Approach to Gene Therapy
Repositioning genes awakens fetal hemoglobin to treat disease. CRISPR editing may change future gene therapy. Researchers ...
Wall Street Expects Editas Medicine to Soar 53%. Is It Time to Buy Now?
The average Wall Street analyst following Editas Medicine ( EDIT 7.08%) thinks the gene therapy stock can reach $3.25 per ...
PipelineReview.com5d
Ono Pharmaceutical and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Japan and South Korea
OSAKA, Japan & BOSTON, MA, USA I June 23, 2025 I Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”) and ...
New gene therapy at Cleveland Clinic aims to end transfusions for thalassemia
A Northeast Ohio woman and a 22-year-old man from UAE are among the first patients to receive the innovative CRISPR treatment ...
A cure for type 1 diabetes? Beta cell replacement with zimislecel achieves insulin independence in early trial
In a clinical trial led by University of Toronto researchers, an allogeneic stem cell–derived islet therapy (zimislecel) ...